FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Junpei Homma

Research Profile

Disorders

Anatomy

Chemicals & Drugs

Procedures

Concepts & Ideas

Physiology

Co-author Network

Publications

TOP 3
Atsushi Kawaguchi; Tsutomu Kobayashi; Yoshihiro Komohara; Yuko Sakai; Masakazu Sano; Naoto Tsuchiya; Naoki Yajima; Hiroshi Aoki; Yukihiko Fujii; Junpei Homma; Hiroaki Hondoh; Yasuo Iwadate; Koji Kajiwara; Tatsuyuki Kakuma; Ryuya Yamanaka
Gene expression signature-based prognostic risk score in patients with primary central nervous system lymphoma.
Ryuya Yamanaka; Ken Morii; Yoshikatsu Shinbo; Junpei Homma; Masakazu Sano; Naoto Tsuchiya; Naoki Yajima; Tetsuro Tamura; Hiroaki Hondoh; Hitoshi Takahashi; Tatsuyuki Kakuma; Ryuichi Tanaka
Results of treatment of 112 cases of primary CNS lymphoma.
Ryuya Yamanaka; Junpei Homma; Masakazu Sano; Naoto Tsuchiya; Naoki Yajima; Hideaki Takahashi; Yoshikatsu Shinbo; Akira Hasegawa; Takashi Saitoh; Ryuichi Tanaka
Salvage immuno-chemotherapy with a combination of rituximab, high-dose cytarabine, mitoxantrone and dexamethasone for patients with primary CNS lymphoma: a preliminary study.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Junpei Homma (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2012: Atsushi Kawaguchi; Tsutomu Kobayashi; Yoshihiro Komohara; Yuko Sakai; Masakazu Sano; Naoto Tsuchiya; Naoki Yajima; Hiroshi Aoki; Yukihiko Fujii; Junpei Homma; Hiroaki Hondoh; Yasuo Iwadate; Koji Kajiwara; Tatsuyuki Kakuma; Ryuya Yamanaka
Gene expression signature-based prognostic risk score in patients with primary central nervous system lymphoma.
Clinical cancer research : an official journal of the American Association for Cancer Research 2012;18(20):5672-81.
2008: Ryuya Yamanaka; Ken Morii; Yoshikatsu Shinbo; Junpei Homma; Masakazu Sano; Naoto Tsuchiya; Naoki Yajima; Tetsuro Tamura; Hiroaki Hondoh; Hitoshi Takahashi; Tatsuyuki Kakuma; Ryuichi Tanaka
Results of treatment of 112 cases of primary CNS lymphoma.
Japanese journal of clinical oncology 2008;38(5):373-80.
2007: Ryuya Yamanaka; Junpei Homma; Masakazu Sano; Naoto Tsuchiya; Naoki Yajima; Hideaki Takahashi; Yoshikatsu Shinbo; Akira Hasegawa; Takashi Saitoh; Ryuichi Tanaka
Salvage immuno-chemotherapy with a combination of rituximab, high-dose cytarabine, mitoxantrone and dexamethasone for patients with primary CNS lymphoma: a preliminary study.
Leukemia & lymphoma 2007;48(7):1429-33.
2007: Ryuya Yamanaka; Yoshikatsu Shinbo; Masakazu Sano; Junpei Homma; Naoto Tsuchiya; Naoki Yajima; Tetsuro Tamura; Hiroaki Hondoh; Hideaki Takahashi; Ken Morii; Kiyoshi Onda; Ryuichi Tanaka
Salvage therapy and late neurotoxicity in patients with recurrent primary CNS lymphoma treated with a modified ProMACE-MOPP hybrid regimen.
Leukemia & lymphoma 2007;48(6):1119-26.
2007: Ryuya Yamanaka; Junpei Homma; Masakazu Sano; Naoto Tsuchiya; Naoki Yajima; Yoshikatsu Shinbo; Akira Hasegawa; Kiyoshi Onda; Ryuichi Tanaka
Immuno-chemotherapy with a combination of rituximab, methotrexate, pirarubicin and procarbazine for patients with primary CNS lymphoma--a preliminary report.
Leukemia & lymphoma 2007;48(5):1019-22.
2006: Masakazu Sano; Nobuyuki Genkai; Naoki Yajima; Naoto Tsuchiya; Junpei Homma; Ryuichi Tanaka; Toru Miki; Ryuya Yamanaka
Expression level of ECT2 proto-oncogene correlates with prognosis in glioma patients.
Oncology reports 2006;16(5):1093-8.
2006: Ryuya Yamanaka; T Arao; Naoki Yajima; Naoto Tsuchiya; Junpei Homma; Ryuichi Tanaka; Masakazu Sano; A Oide; Masaru Sekijima; Kazuto Nishio
Identification of expressed genes characterizing long-term survival in malignant glioma patients.
Oncogene 2006;25(44):5994-6002.
2006: Nobuyuki Genkai; Junpei Homma; Masakazu Sano; Ryuichi Tanaka; Ryuya Yamanaka
Increased expression of pituitary tumor-transforming gene (PTTG)-1 is correlated with poor prognosis in glioma patients.
Oncology reports 2006;15(6):1569-74.
2006: Junpei Homma; Ryuya Yamanaka; Naoki Yajima; Naoto Tsuchiya; Nobuyuki Genkai; Masakazu Sano; Ryuichi Tanaka
Increased expression of CCAAT/enhancer binding protein beta correlates with prognosis in glioma patients.
Oncology reports 2006;15(3):595-601.
2005: Naoto Tsuchiya; Ryuya Yamanaka; Naoki Yajima; Junpei Homma; Masakazu Sano; Tadashi Komata; Takeshi Ikeda; Ichiro Fujimoto; Hitoshi Takahashi; Ryuichi Tanaka; Kazuhiro Ikenaka
Isolation and characterization of an N-linked oligosaccharide that is increased in glioblastoma tissue and cell lines.
International journal of oncology 2005;27(5):1231-9.
2005: Naoki Yajima; Ryuya Yamanaka; Takashi Mine; Naoto Tsuchiya; Junpei Homma; Masakazu Sano; Terukazu Kuramoto; Yayoi Obata; Nobukazu Komatsu; Yoshimi Arima; Akira Yamada; Minoru Shigemori; Kyogo Itoh; Ryuichi Tanaka
Immunologic evaluation of personalized peptide vaccination for patients with advanced malignant glioma.
Clinical cancer research : an official journal of the American Association for Cancer Research 2005;11(16):5900-11.
2005: Ryuya Yamanaka; Junpei Homma; Naoki Yajima; Naoto Tsuchiya; Masakazu Sano; Tsutomu Kobayashi; Seiichi Yoshida; Takashi Abe; Miwako Narita; Masuhiro Takahashi; Ryuichi Tanaka
Clinical evaluation of dendritic cell vaccination for patients with recurrent glioma: results of a clinical phase I/II trial.
Clinical cancer research : an official journal of the American Association for Cancer Research 2005;11(11):4160-7.
2003: Ryuya Yamanaka; Takashi Abe; Naoki Yajima; Naoto Tsuchiya; Junpei Homma; Tsutomu Kobayashi; Miwako Narita; Masuhiro Takahashi; Ryuichi Tanaka
Vaccination of recurrent glioma patients with tumour lysate-pulsed dendritic cells elicits immune responses: results of a clinical phase I/II trial.
British journal of cancer 2003;89(7):1172-9.
2003: Tsutomu Kobayashi; Ryuya Yamanaka; Junpei Homma; Naoto Tsuchiya; Naoki Yajima; Seiichi Yoshida; Ryuichi Tanaka
Tumor mRNA-loaded dendritic cells elicit tumor-specific CD8(+) cytotoxic T cells in patients with malignant glioma.
Cancer immunology, immunotherapy : CII 2003;52(10):632-7.
2003: Ryuya Yamanaka; Junpei Homma; Naoki Yajima; Naoto Tsuchiya; Ryuichi Tanaka
[Dendritic cell therapy for malignant glioma].
Nō to shinkei = Brain and nerve 2003;55(9):771-80.
2003: Ryuya Yamanaka; Naoki Yajima; Takashi Abe; Naoto Tsuchiya; Junpei Homma; Miwako Narita; Masuhiro Takahashi; Ryuichi Tanaka
Dendritic cell-based glioma immunotherapy (review).
International journal of oncology 2003;23(1):5-15.